APO Research

APO RESEARCH · REPORT

Flu Shots

Selected research

Market Analysis & Forecast

Global Flu Shots Market Analysis and Forecast 2026-2032

Market perspective

The global Flu Shots market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flu Shots is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Flu Shots is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Flu Shots is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Flu Shots is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Flu Shots include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flu Shots, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Flu Shots, also provides the sales of main regions and countries. Of the upcoming market potential for Flu Shots, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu Shots sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Flu Shots market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Flu Shots sales, projected growth trends, production technology, application and end-user industry.

Flu Shots Segment by Company

SANOFI

GSK

VAXTEC

TIANYUAN BIO-PHARMA

SIOBP

SINOVAC

LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT

HUALAN BIO

CHANGSHENG

CCBIO

ALEPH BIOMEDICAL

Flu Shots Segment by Type

Influenza Whole Virus Vaccines

Influenza Virus Subunit Vaccines

Influenza Virus Split Vaccines

Flu Shots Segment by Application

Avian Influenza Virus-A

Avian Influenza Virus-B

Flu Shots Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Flu Shots in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu Shots sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Flu Shots Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Influenza Whole Virus Vaccines Major Manufacturers Table 3. Influenza Virus Subunit Vaccines Major Manufacturers Table 4. Influenza Virus Split Vaccines Major Manufacturers Table 5. Global Flu Shots Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Avian Influenza Virus-A Major Manufacturers Table 7. Avian Influenza Virus-B Major Manufacturers Table 8. Flu Shots Industry Trends Table 9. Flu Shots Industry Drivers Table 10. Flu Shots Industry Opportunities and Challenges Table 11. Flu Shots Industry Restraints Table 12. Global Flu Shots Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Flu Shots Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Flu Shots Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Flu Shots Revenue Market Share by Region (2021-2026) Table 16. Global Flu Shots Revenue Market Share by Region (2027-2032) Table 17. Global Flu Shots Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Flu Shots Sales by Region (2021-2026) & (K Units) Table 19. Global Flu Shots Sales by Region (2027-2032) & (K Units) Table 20. Global Flu Shots Sales Market Share by Region (2021-2026) Table 21. Global Flu Shots Sales Market Share by Region (2027-2032) Table 22. Global Flu Shots Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Flu Shots Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Flu Shots Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Flu Shots Sales Market Share by Manufacturers (2021-2026) Table 26. Global Flu Shots Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Flu Shots Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Flu Shots Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Flu Shots Manufacturers, Product Type & Application Table 30. Global Flu Shots Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Flu Shots by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Flu Shots Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Flu Shots Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Flu Shots Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Flu Shots Revenue Market Share by Type (2021-2026) Table 37. Global Flu Shots Revenue Market Share by Type (2027-2032) Table 38. Global Flu Shots Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Flu Shots Sales by Type (2021-2026) & (K Units) Table 40. Global Flu Shots Sales by Type (2027-2032) & (K Units) Table 41. Global Flu Shots Sales Market Share by Type (2021-2026) Table 42. Global Flu Shots Sales Market Share by Type (2027-2032) Table 43. Global Flu Shots Price by Type (2021-2026) & (US$/Unit) Table 44. Global Flu Shots Price by Type (2027-2032) & (US$/Unit) Table 45. Global Flu Shots Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Flu Shots Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Flu Shots Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Flu Shots Revenue Market Share by Application (2021-2026) Table 49. Global Flu Shots Revenue Market Share by Application (2027-2032) Table 50. Global Flu Shots Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Flu Shots Sales by Application (2021-2026) & (K Units) Table 52. Global Flu Shots Sales by Application (2027-2032) & (K Units) Table 53. Global Flu Shots Sales Market Share by Application (2021-2026) Table 54. Global Flu Shots Sales Market Share by Application (2027-2032) Table 55. Global Flu Shots Price by Application (2021-2026) & (US$/Unit) Table 56. Global Flu Shots Price by Application (2027-2032) & (US$/Unit) Table 57. SANOFI Company Information Table 58. SANOFI Business Overview Table 59. SANOFI Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. SANOFI Flu Shots Product Portfolio Table 61. SANOFI Recent Development Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. GSK Flu Shots Product Portfolio Table 66. GSK Recent Development Table 67. VAXTEC Company Information Table 68. VAXTEC Business Overview Table 69. VAXTEC Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. VAXTEC Flu Shots Product Portfolio Table 71. VAXTEC Recent Development Table 72. TIANYUAN BIO-PHARMA Company Information Table 73. TIANYUAN BIO-PHARMA Business Overview Table 74. TIANYUAN BIO-PHARMA Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. TIANYUAN BIO-PHARMA Flu Shots Product Portfolio Table 76. TIANYUAN BIO-PHARMA Recent Development Table 77. SIOBP Company Information Table 78. SIOBP Business Overview Table 79. SIOBP Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SIOBP Flu Shots Product Portfolio Table 81. SIOBP Recent Development Table 82. SINOVAC Company Information Table 83. SINOVAC Business Overview Table 84. SINOVAC Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. SINOVAC Flu Shots Product Portfolio Table 86. SINOVAC Recent Development Table 87. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information Table 88. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview Table 89. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio Table 91. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Development Table 92. HUALAN BIO Company Information Table 93. HUALAN BIO Business Overview Table 94. HUALAN BIO Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. HUALAN BIO Flu Shots Product Portfolio Table 96. HUALAN BIO Recent Development Table 97. CHANGSHENG Company Information Table 98. CHANGSHENG Business Overview Table 99. CHANGSHENG Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. CHANGSHENG Flu Shots Product Portfolio Table 101. CHANGSHENG Recent Development Table 102. CCBIO Company Information Table 103. CCBIO Business Overview Table 104. CCBIO Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. CCBIO Flu Shots Product Portfolio Table 106. CCBIO Recent Development Table 107. ALEPH BIOMEDICAL Company Information Table 108. ALEPH BIOMEDICAL Business Overview Table 109. ALEPH BIOMEDICAL Flu Shots Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. ALEPH BIOMEDICAL Flu Shots Product Portfolio Table 111. ALEPH BIOMEDICAL Recent Development Table 112. North America Flu Shots Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Flu Shots Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Flu Shots Sales by Type (2021-2026) & (K Units) Table 115. North America Flu Shots Sales by Type (2027-2032) & (K Units) Table 116. North America Flu Shots Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Flu Shots Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Flu Shots Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Flu Shots Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Flu Shots Sales by Application (2021-2026) & (K Units) Table 121. North America Flu Shots Sales by Application (2027-2032) & (K Units) Table 122. North America Flu Shots Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Flu Shots Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Flu Shots Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Flu Shots Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Flu Shots Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Flu Shots Sales by Country (2021-2026) & (K Units) Table 129. North America Flu Shots Sales by Country (2027-2032) & (K Units) Table 130. North America Flu Shots Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Flu Shots Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Flu Shots Revenue (2021-2032) & (US$ Million) Table 133. Canada Flu Shots Revenue (2021-2032) & (US$ Million) Table 134. Europe Flu Shots Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Flu Shots Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Flu Shots Sales by Type (2021-2026) & (K Units) Table 137. Europe Flu Shots Sales by Type (2027-2032) & (K Units) Table 138. Europe Flu Shots Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Flu Shots Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Flu Shots Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Flu Shots Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Flu Shots Sales by Application (2021-2026) & (K Units) Table 143. Europe Flu Shots Sales by Application (2027-2032) & (K Units) Table 144. Europe Flu Shots Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Flu Shots Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Flu Shots Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Flu Shots Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Flu Shots Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Europe Flu Shots Sales by Country (2021-2026) & (K Units) Table 151. Europe Flu Shots Sales by Country (2027-2032) & (K Units) Table 152. Europe Flu Shots Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Flu Shots Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Flu Shots Revenue (2021-2032) & (US$ Million) Table 155. France Flu Shots Revenue (2021-2032) & (US$ Million) Table 156. U.K. Flu Shots Revenue (2021-2032) & (US$ Million) Table 157. Italy Flu Shots Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Flu Shots Revenue (2021-2032) & (US$ Million) Table 159. China Flu Shots Revenue by Type (2021-2026) & (US$ Million) Table 160. China Flu Shots Revenue by Type (2027-2032) & (US$ Million) Table 161. China Flu Shots Sales by Type (2021-2026) & (K Units) Table 162. China Flu Shots Sales by Type (2027-2032) & (K Units) Table 163. China Flu Shots Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Flu Shots Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Flu Shots Revenue by Application (2021-2026) & (US$ Million) Table 166. China Flu Shots Revenue by Application (2027-2032) & (US$ Million) Table 167. China Flu Shots Sales by Application (2021-2026) & (K Units) Table 168. China Flu Shots Sales by Application (2027-2032) & (K Units) Table 169. China Flu Shots Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Flu Shots Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Flu Shots Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Flu Shots Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Flu Shots Sales by Type (2021-2026) & (K Units) Table 174. Asia Flu Shots Sales by Type (2027-2032) & (K Units) Table 175. Asia Flu Shots Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Flu Shots Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Flu Shots Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Flu Shots Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Flu Shots Sales by Application (2021-2026) & (K Units) Table 180. Asia Flu Shots Sales by Application (2027-2032) & (K Units) Table 181. Asia Flu Shots Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Flu Shots Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Flu Shots Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Flu Shots Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Flu Shots Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Flu Shots Sales by Country (2021-2026) & (K Units) Table 188. Asia Flu Shots Sales by Country (2027-2032) & (K Units) Table 189. Asia Flu Shots Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Flu Shots Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Flu Shots Revenue (2021-2032) & (US$ Million) Table 192. South Korea Flu Shots Revenue (2021-2032) & (US$ Million) Table 193. India Flu Shots Revenue (2021-2032) & (US$ Million) Table 194. Australia Flu Shots Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Flu Shots Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Flu Shots Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Flu Shots Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Flu Shots Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Flu Shots Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Flu Shots Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Flu Shots Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Flu Shots Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Flu Shots Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Flu Shots Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Flu Shots Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Flu Shots Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Flu Shots Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Flu Shots Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Flu Shots Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Flu Shots Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Flu Shots Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Flu Shots Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Flu Shots Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Flu Shots Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Flu Shots Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Flu Shots Revenue (2021-2032) & (US$ Million) Table 218. Argentina Flu Shots Revenue (2021-2032) & (US$ Million) Table 219. Chile Flu Shots Revenue (2021-2032) & (US$ Million) Table 220. Colombia Flu Shots Revenue (2021-2032) & (US$ Million) Table 221. Peru Flu Shots Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Flu Shots Revenue (2021-2032) & (US$ Million) Table 223. Israel Flu Shots Revenue (2021-2032) & (US$ Million) Table 224. UAE Flu Shots Revenue (2021-2032) & (US$ Million) Table 225. Turkey Flu Shots Revenue (2021-2032) & (US$ Million) Table 226. Iran Flu Shots Revenue (2021-2032) & (US$ Million) Table 227. Egypt Flu Shots Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Flu Shots Distributors List Table 231. Flu Shots Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Flu Shots Image Figure 2. Global Flu Shots Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Shots Market Size Share 2021 VS 2025 VS 2032 Figure 4. Influenza Whole Virus Vaccines Image Figure 5. Influenza Virus Subunit Vaccines Image Figure 6. Influenza Virus Split Vaccines Image Figure 7. Global Flu Shots Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Flu Shots Market Size Share 2021 VS 2025 VS 2032 Figure 9. Avian Influenza Virus-A Image Figure 10. Avian Influenza Virus-B Image Figure 11. Global Flu Shots Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Flu Shots Revenue (2021-2032) & (US$ Million) Figure 13. Global Flu Shots Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Flu Shots Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Flu Shots Revenue Market Share by Region (2021-2032) Figure 16. Global Flu Shots Sales (2021-2032) & (K Units) Figure 17. Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Flu Shots Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Flu Shots Sales YoY (2021-2032) & (K Units) Figure 20. Europe Flu Shots Sales YoY (2021-2032) & (K Units) Figure 21. China Flu Shots Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Flu Shots Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Flu Shots Sales YoY (2021-2032) & (K Units) Figure 24. Global Flu Shots Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Flu Shots Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Flu Shots Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Flu Shots Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Flu Shots Revenue Market Share by Type (2021-2032) Figure 30. Global Flu Shots Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Flu Shots Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Flu Shots Sales Market Share by Type (2021-2032) Figure 33. Global Flu Shots Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Flu Shots Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Flu Shots Revenue Market Share by Application (2021-2032) Figure 36. Global Flu Shots Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Flu Shots Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Flu Shots Sales Market Share by Application (2021-2032) Figure 39. North America Flu Shots Revenue Share by Type (2021-2032) Figure 40. North America Flu Shots Sales Share by Type (2021-2032) Figure 41. North America Flu Shots Revenue Share by Application (2021-2032) Figure 42. North America Flu Shots Sales Share by Application (2021-2032) Figure 43. North America Flu Shots Revenue Share by Country (2021-2032) Figure 44. North America Flu Shots Sales Share by Country (2021-2032) Figure 45. Europe Flu Shots Revenue Share by Type (2021-2032) Figure 46. Europe Flu Shots Sales Share by Type (2021-2032) Figure 47. Europe Flu Shots Revenue Share by Application (2021-2032) Figure 48. Europe Flu Shots Sales Share by Application (2021-2032) Figure 49. Europe Flu Shots Revenue Share by Country (2021-2032) Figure 50. Europe Flu Shots Sales Share by Country (2021-2032) Figure 51. China Flu Shots Revenue Share by Type (2021-2032) Figure 52. China Flu Shots Sales Share by Type (2021-2032) Figure 53. China Flu Shots Revenue Share by Application (2021-2032) Figure 54. China Flu Shots Sales Share by Application (2021-2032) Figure 55. Asia Flu Shots Revenue Share by Type (2021-2032) Figure 56. Asia Flu Shots Sales Share by Type (2021-2032) Figure 57. Asia Flu Shots Revenue Share by Application (2021-2032) Figure 58. Asia Flu Shots Sales Share by Application (2021-2032) Figure 59. Asia Flu Shots Revenue Share by Country (2021-2032) Figure 60. Asia Flu Shots Sales Share by Country (2021-2032) Figure 61. SAMEA Flu Shots Revenue Share by Type (2021-2032) Figure 62. SAMEA Flu Shots Sales Share by Type (2021-2032) Figure 63. SAMEA Flu Shots Revenue Share by Application (2021-2032) Figure 64. SAMEA Flu Shots Sales Share by Application (2021-2032) Figure 65. SAMEA Flu Shots Revenue Share by Country (2021-2032) Figure 66. SAMEA Flu Shots Sales Share by Country (2021-2032) Figure 67. Flu Shots Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Flu Shots Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Whole Virus Vaccines
  • Influenza Virus Subunit Vaccines
  • Influenza Virus Split Vaccines
Applications
  • Avian Influenza Virus-A
  • Avian Influenza Virus-B
Companies covered
  • SANOFI
  • GSK
  • VAXTEC
  • TIANYUAN BIO-PHARMA
  • SIOBP
  • SINOVAC
  • LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  • HUALAN BIO
  • CHANGSHENG
  • CCBIO
  • ALEPH BIOMEDICAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Flu Shots Market by Type
  3. 1.2.1 Global Flu Shots Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Influenza Whole Virus Vaccines
  5. 1.2.3 Influenza Virus Subunit Vaccines
  6. 1.2.4 Influenza Virus Split Vaccines
  7. 1.3 Flu Shots Market by Application
  8. 1.3.1 Global Flu Shots Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Avian Influenza Virus-A
  10. 1.3.3 Avian Influenza Virus-B
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Flu Shots Market Dynamics
  1. 2.1 Flu Shots Industry Trends
  2. 2.2 Flu Shots Industry Drivers
  3. 2.3 Flu Shots Industry Opportunities and Challenges
  4. 2.4 Flu Shots Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Flu Shots Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Flu Shots Revenue by Region
  3. 3.2.1 Global Flu Shots Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Flu Shots Revenue by Region (2021-2026)
  5. 3.2.3 Global Flu Shots Revenue by Region (2027-2032)
  6. 3.2.4 Global Flu Shots Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Flu Shots Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Flu Shots Sales by Region
  9. 3.4.1 Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Flu Shots Sales by Region (2021-2026)
  11. 3.4.3 Global Flu Shots Sales by Region (2027-2032)
  12. 3.4.4 Global Flu Shots Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Flu Shots Revenue by Manufacturers
  2. 4.1.1 Global Flu Shots Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Flu Shots Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Flu Shots Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Flu Shots Sales by Manufacturers
  6. 4.2.1 Global Flu Shots Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Flu Shots Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Flu Shots Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Flu Shots Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Flu Shots Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Flu Shots Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Flu Shots Manufacturers, Product Type & Application
  13. 4.7 Global Flu Shots Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Flu Shots Market CR5 and HHI
  16. 4.8.2 2025 Flu Shots Tier 1, Tier 2, and Tier 3
5 Flu Shots Market by Type
  1. 5.1 Global Flu Shots Revenue by Type
  2. 5.1.1 Global Flu Shots Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Flu Shots Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Flu Shots Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Flu Shots Sales by Type
  6. 5.2.1 Global Flu Shots Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flu Shots Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Flu Shots Sales Market Share by Type (2021-2032)
  9. 5.3 Global Flu Shots Price by Type
6 Flu Shots Market by Application
  1. 6.1 Global Flu Shots Revenue by Application
  2. 6.1.1 Global Flu Shots Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Flu Shots Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Flu Shots Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Flu Shots Sales by Application
  6. 6.2.1 Global Flu Shots Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Flu Shots Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Flu Shots Sales Market Share by Application (2021-2032)
  9. 6.3 Global Flu Shots Price by Application
7 Company Profiles
  1. 7.1 SANOFI
  2. 7.1.1 SANOFI Company Information
  3. 7.1.2 SANOFI Business Overview
  4. 7.1.3 SANOFI Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SANOFI Flu Shots Product Portfolio
  6. 7.1.5 SANOFI Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Flu Shots Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 VAXTEC
  14. 7.3.1 VAXTEC Company Information
  15. 7.3.2 VAXTEC Business Overview
  16. 7.3.3 VAXTEC Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 VAXTEC Flu Shots Product Portfolio
  18. 7.3.5 VAXTEC Recent Developments
  19. 7.4 TIANYUAN BIO-PHARMA
  20. 7.4.1 TIANYUAN BIO-PHARMA Company Information
  21. 7.4.2 TIANYUAN BIO-PHARMA Business Overview
  22. 7.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
  24. 7.4.5 TIANYUAN BIO-PHARMA Recent Developments
  25. 7.5 SIOBP
  26. 7.5.1 SIOBP Company Information
  27. 7.5.2 SIOBP Business Overview
  28. 7.5.3 SIOBP Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SIOBP Flu Shots Product Portfolio
  30. 7.5.5 SIOBP Recent Developments
  31. 7.6 SINOVAC
  32. 7.6.1 SINOVAC Company Information
  33. 7.6.2 SINOVAC Business Overview
  34. 7.6.3 SINOVAC Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 SINOVAC Flu Shots Product Portfolio
  36. 7.6.5 SINOVAC Recent Developments
  37. 7.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  38. 7.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
  39. 7.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
  40. 7.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
  42. 7.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
  43. 7.8 HUALAN BIO
  44. 7.8.1 HUALAN BIO Company Information
  45. 7.8.2 HUALAN BIO Business Overview
  46. 7.8.3 HUALAN BIO Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 HUALAN BIO Flu Shots Product Portfolio
  48. 7.8.5 HUALAN BIO Recent Developments
  49. 7.9 CHANGSHENG
  50. 7.9.1 CHANGSHENG Company Information
  51. 7.9.2 CHANGSHENG Business Overview
  52. 7.9.3 CHANGSHENG Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CHANGSHENG Flu Shots Product Portfolio
  54. 7.9.5 CHANGSHENG Recent Developments
  55. 7.10 CCBIO
  56. 7.10.1 CCBIO Company Information
  57. 7.10.2 CCBIO Business Overview
  58. 7.10.3 CCBIO Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CCBIO Flu Shots Product Portfolio
  60. 7.10.5 CCBIO Recent Developments
  61. 7.11 ALEPH BIOMEDICAL
  62. 7.11.1 ALEPH BIOMEDICAL Company Information
  63. 7.11.2 ALEPH BIOMEDICAL Business Overview
  64. 7.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
  66. 7.11.5 ALEPH BIOMEDICAL Recent Developments
8 North America
  1. 8.1 North America Flu Shots Market Size by Type
  2. 8.1.1 North America Flu Shots Revenue by Type (2021-2032)
  3. 8.1.2 North America Flu Shots Sales by Type (2021-2032)
  4. 8.1.3 North America Flu Shots Price by Type (2021-2032)
  5. 8.2 North America Flu Shots Market Size by Application
  6. 8.2.1 North America Flu Shots Revenue by Application (2021-2032)
  7. 8.2.2 North America Flu Shots Sales by Application (2021-2032)
  8. 8.2.3 North America Flu Shots Price by Application (2021-2032)
  9. 8.3 North America Flu Shots Market Size by Country
  10. 8.3.1 North America Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Flu Shots Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Flu Shots Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Flu Shots Market Size by Type
  2. 9.1.1 Europe Flu Shots Revenue by Type (2021-2032)
  3. 9.1.2 Europe Flu Shots Sales by Type (2021-2032)
  4. 9.1.3 Europe Flu Shots Price by Type (2021-2032)
  5. 9.2 Europe Flu Shots Market Size by Application
  6. 9.2.1 Europe Flu Shots Revenue by Application (2021-2032)
  7. 9.2.2 Europe Flu Shots Sales by Application (2021-2032)
  8. 9.2.3 Europe Flu Shots Price by Application (2021-2032)
  9. 9.3 Europe Flu Shots Market Size by Country
  10. 9.3.1 Europe Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Flu Shots Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Flu Shots Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Flu Shots Market Size by Type
  2. 10.1.1 China Flu Shots Revenue by Type (2021-2032)
  3. 10.1.2 China Flu Shots Sales by Type (2021-2032)
  4. 10.1.3 China Flu Shots Price by Type (2021-2032)
  5. 10.2 China Flu Shots Market Size by Application
  6. 10.2.1 China Flu Shots Revenue by Application (2021-2032)
  7. 10.2.2 China Flu Shots Sales by Application (2021-2032)
  8. 10.2.3 China Flu Shots Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Flu Shots Market Size by Type
  2. 11.1.1 Asia Flu Shots Revenue by Type (2021-2032)
  3. 11.1.2 Asia Flu Shots Sales by Type (2021-2032)
  4. 11.1.3 Asia Flu Shots Price by Type (2021-2032)
  5. 11.2 Asia Flu Shots Market Size by Application
  6. 11.2.1 Asia Flu Shots Revenue by Application (2021-2032)
  7. 11.2.2 Asia Flu Shots Sales by Application (2021-2032)
  8. 11.2.3 Asia Flu Shots Price by Application (2021-2032)
  9. 11.3 Asia Flu Shots Market Size by Country
  10. 11.3.1 Asia Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Flu Shots Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Flu Shots Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Flu Shots Market Size by Type
  2. 12.1.1 SAMEA Flu Shots Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Flu Shots Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Flu Shots Price by Type (2021-2032)
  5. 12.2 SAMEA Flu Shots Market Size by Application
  6. 12.2.1 SAMEA Flu Shots Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Flu Shots Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Flu Shots Price by Application (2021-2032)
  9. 12.3 SAMEA Flu Shots Market Size by Country
  10. 12.3.1 SAMEA Flu Shots Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Flu Shots Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Flu Shots Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Flu Shots Value Chain Analysis
  2. 13.1.1 Flu Shots Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Flu Shots Production Mode & Process
  6. 13.2 Flu Shots Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Flu Shots Distributors
  9. 13.2.3 Flu Shots Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research